Apolipoprotein C-I Antibody Properties Description Anti-Apolipoprotein C-I (GOAT) Antibody - 600-101-112 Host Goat Target Species Human Known Cross Reactivity human Clonality Polyclonal Application ELISA : 1:5,000 - 1:10,000 Western Blot : 1:5,000 - 1:10,000 Immunohistochemistry: 1:50 - 1:200 ImmunoPrecipitation: 1:100 Other Dilution: User Optimized Physical State Liquid (sterile filtered) Shipping Condition Wet Ice Format IgG Label Unconjugated Concentration 1.0 mg/mL by UV absorbance at 280 nm Buffer 0.125 M Sodium Borate, 0.075 M Sodium Chloride, 0.005 M EDTA, pH 8.0 Preservative 0.01% (w/v) Sodium Azide Stabilizer None GeneName APOC1 Relevant Links UniProtKB - P02654NCBI - P02654.1GeneID - 341

Apolipoprotein C-I Antibody Description

Background This antibody is suitable for cardiovascular research. Synonyms goat anti-Apolipoprotein C-I Antibody, Apo-C1, ApoC-1, APOC1 antibody, Apolipoprotein CI, Apolipoprotein C I antibody Immunogen apoLipoprotein Type C-I produced synthetically in full-length form (not selected epitopes) using conventional peptide technology. Immunogen Type Peptide Storage Condition Store vial at 4° C prior to opening.  This product is stable at 4° C as an undiluted liquid.  Dilute only prior to immediate use.  For extended storage, mix with an equal volume of glycerol, aliquot contents and freeze at -20° C or below.  Avoid cycles of freezing and thawing.  Application Note Anti-apoLipoprotein antibodies have been used for indirect trapping ELISA for quantitation of antigen in serum using a standard curve, for immunoprecipitation and for western blotting for highly sensitive qualitative analysis. Purity/Specifity This product has been prepared by immunoaffinity chromatography using immobilized antigens followed by extensive cross-adsorption against other apoLipoproteins and human serum proteins to remove any unwanted specificities.  Typically less than 1% cross reactivity against other types of apoLipoprotein was detected by ELISA against purified standards.  This antibody reacts with human apoLipoprotein C-I and has negligible cross-reactivity with Type A-I, A-II, B, C-II, C-III, E and J apoLipoproteins.  Specific cross reaction of anti-apoLipoprotein antibodies with antigens from other species has not been determined.  Non-specific cross reaction of anti-apoLipoprotein antibodies with other human serum proteins is negligible. Disclaimer Note-General This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information. All products of animal origin manufactured by Rockland Immunochemicals are derived from starting materials of North American origin. Collection was performed in United States Department of Agriculture (USDA) inspected facilities and all materials have been inspected and certified to be free of disease and suitable for exportation. All properties listed are typical characteristics and are not specifications. All suggestions and data are offered in good faith but without guarantee as conditions and methods of use of our products are beyond our control. All claims must be made within 30 days following the date of delivery. The prospective user must determine the suitability of our materials before adopting them on a commercial scale. Suggested uses of our products are not recommendations to use our products in violation of any patent or as a license under any patent of Rockland Immunochemicals, Inc. If you require a commercial license to use this material and do not have one, then return this material, unopened to: Rockland Inc., P.O. BOX 5199, Limerick, Pennsylvania, USA.